

patient's on 10mg/kg do not do as well on SQ

Vedo - less effective in TNF failure, longer response
inductin with IV then SQ

S1P - Ozanimod / Oral therapyt
concerns about CV, herpes
worse if prior biologic exposure
not good for pregnancy, h of macular edema/uveitis

IL23 p 19
mirikizumab (Omvoh) - 
guselkumab (Tremfya)
-good 2nd line agents for CD
(not goood for HepB)

Ustekinumab (Stelara)- very low immunogencity (IV induction)

Jack2
Upadacitnib JAK1
(only if you wouldn't start TNF)
CV and smoking, shingles risk
